Today: 11 June 2026
Citigroup stock ticks up as CPI, Citi earnings set next test
9 January 2026
1 min read

Citigroup stock ticks up as CPI, Citi earnings set next test

New York, January 9, 2026, 12:49 (ET) — Regular session

  • Citigroup shares rose about 0.8% in midday trade
  • Investors are positioning for big-bank earnings and U.S. inflation data next week
  • Analysts see a rebound in investment banking and capital markets driving results

Citigroup shares were up 0.8% at $121.53 on Friday, with investors leaning into the start of U.S. bank earnings season next week and a key inflation report that could shift rate bets.

Stocks have opened 2026 calmly, but strategists say the quiet could break as earnings and macro data hit. “As we’re starting January, the market may be underappreciating some of the events on the horizon,” Michael Arone, chief investment strategist at State Street Investment Management, said. Reuters

The bank reports start with JPMorgan on Jan. 13, followed by Citigroup, Bank of America and Wells Fargo on Jan. 14, Reuters reported. Analysts see Citigroup’s earnings per share — a common profit gauge — rising 32% from a year earlier, helped by stronger capital markets, while Morningstar analyst Sean Dunlop said inflation is “the biggest variable” he is watching into earnings. Reuters

Citigroup will release its fourth-quarter 2025 results at about 8 a.m. ET on Wednesday, Jan. 14, and hold a webcast and conference call at 11 a.m., the bank said.

The Consumer Price Index for December 2025 is scheduled for release on Tuesday, Jan. 13 at 8:30 a.m. ET, the Labor Department said, putting inflation back at the center of the rate debate.

The Federal Reserve’s next policy meeting is set for Jan. 27-28, according to the central bank’s 2026 calendar.

Citigroup entered 2026 trading above book value for the first time since 2008 after a roughly 70% gain in 2025, the Wall Street Journal reported, a run that has raised the bar for the next set of numbers. Analysts have said they want to see progress toward Citi’s 10% to 11% return on tangible common equity target — profit relative to a stripped-down measure of capital — by end-2026.

But the setup can turn fast. A hotter CPI print could knock back expectations for further Fed cuts, while any hint of softer deal flow or rising credit stress would test a stock that has already repriced sharply.

The next dates in focus are Tuesday’s CPI release and Wednesday’s Citigroup results, with investors also eyeing the bank’s May 7 investor day on its calendar for its next longer-range update.

Stock Market Today

  • Coupang Shares Rise After South Korea Imposes $410 Million Data Breach Fine
    June 11, 2026, 10:43 AM EDT. Coupang, the New York-listed South Korean e-commerce company, saw its shares rise 5.6% to $15.96 following a record $410 million fine from the Personal Information Protection Commission (PIPC) for a major data breach affecting over 37 million users. The fine includes penalties for a November 2025 incident and unauthorized data tracking via a third-party ad program. Coupang expects the penalty to impact its second-quarter operating expenses but plans to seek judicial relief. The regulator attributed the breach to a lack of proper safety measures, estimating the fine at approximately 1.4% of Coupang's 2025 revenue of 45 trillion won. Investors are monitoring whether this will lead to lasting effects on customer trust and profit margins.

Latest articles

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves
Previous Story

Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop